[Federal Register Volume 68, Number 25 (Thursday, February 6, 2003)]
[Notices]
[Pages 6184-6185]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-2920]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 1, 2002, Noramco, 
Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to support its other manufacturing facility with 
manufacturing and analytical testing.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances

[[Page 6185]]

may file comments or objections to the issuance of the proposed 
registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 7, 2003.

    Dated: January 27, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-2920 Filed 2-5-03; 8:45 am]
BILLING CODE 4410-09-M